An influenza vaccine made of stabilized mRNA may allow vaccine design and manufacture to keep pace with viral evolution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lothar, S. et al. Nat. Biotechnol. 30, 1210–1216 (2012).
Fiore, A.E., Bridges, C.B. & Cox, N.J. Curr. Top. Microbiol. Immunol. 333, 43–82 (2009).
Ulmer, J.B., Mason, P.W., Geall, A. & Mandl, C.W. Vaccine 30, 4414–4418 (2012).
Hoerr, I., Obst, R., Rammensee, H.G. & Jung, G. Eur. J. Immunol. 30, 1–7 (2000).
Shinya, K. et al. Nature 440, 435–436 (2006).
Pearce, M.B., Belser, J.A., Houser, K.V., Katz, J.M. & Tumpey, T.M. Vaccine 29, 2887–2894 (2011).
Louz, D., Bergmans, H.E., Loos, B.P. & Hoeben, R.C. Crit. Rev. Microbiol. (2012).
Richardson, J.S., Dekker, J.D., Croyle, M.A. & Kobinger, G.P. Hum. Vaccin. 6, 439–449 (2010).
Dejnirattisai, W. et al. Science 328, 745–748 (2010).
Corti, D. et al. Science 333, 850–856 (2011).
Ekiert, D.C. et al. Nature 489, 526–532 (2012).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wong, SS., Webby, R. An mRNA vaccine for influenza. Nat Biotechnol 30, 1202–1204 (2012). https://doi.org/10.1038/nbt.2439
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2439
This article is cited by
-
Preparation of Small RNAs Using Rolling Circle Transcription and Site-Specific RNA Disconnection
Molecular Therapy - Nucleic Acids (2015)
-
Adjuvant effect of CD40 on H5N1 DNA vaccine in mice
Archives of Virology (2014)